How MS Patients Lost Their Patience, Got Mouthy, and the FDA Listened
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- The FDA Is Basically Approving Everything. Here's The Data To Prove It, by Matthew Herper, Forbes. August 20, 2015. www.forbes.com/sites/matthewherper/2015/08/20/the-fda-is-basically-approving-everything-heres-the-data-to-prove-it/#280025435e0a
- FDA Lets MS Drug Tysabri Return Strict Rules Focus on Rare, Potentially Deadly Brain Infection, by Miranda Hitti, WebMD. June 5, 2006. www.webmd.com/multiple-sclerosis/news/20060605/fda-lets-ms-drug-tysabri-return#1